Although this was the first study investigating the risk of thyroid cancer with GLP-1 RAs in a large administrative database, caution is required in generalizing these observations to clinical practice because of inherent study limitations (i.e., database misclassification and other potential confounders). The gene discussed is GCG; the disease is thyroid cancer.